Related references
Note: Only part of the references are listed.CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase
Qasim A. Khan et al.
PLOS ONE (2018)
Census and evaluation of p53 target genes
M. Fischer
ONCOGENE (2017)
Reviving the guardian of the genome: Small molecule activators of p53
Daniel Nguyen et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Sphingolipids in mitochondria
Maria Jose Hernandez-Corbacho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
CRISPR-Cas9-based target validation for p53-reactivating model compounds
Ichael Wanzel et al.
NATURE CHEMICAL BIOLOGY (2016)
2016 update of the PRIDE database and its related tools
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2016)
LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity
Z. Jiang et al.
CURRENT MOLECULAR MEDICINE (2016)
CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress
Baharan Fekry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Denise Martinez-Zapien et al.
NATURE (2016)
C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling
Min-Bin Chen et al.
CARCINOGENESIS (2015)
Serum deprivation alters lipid profile in HN9.10e embryonic hippocampal cells
Mercedes Garcia-Gil et al.
NEUROSCIENCE LETTERS (2015)
The role of ubiquitin modification in the regulation of p53
Andreas K. Hock et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
Bo Hong et al.
CURRENT DRUG TARGETS (2014)
Limiting the power of p53 through the ubiquitin proteasome pathway
Vinod Pant et al.
GENES & DEVELOPMENT (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Live-cell imaging of p53 interactions using a novel Venus-based bimolecular fluorescence complementation system
Joana Dias Amaral et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6
L. Alexis Hoeferlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Ceramide Synthases Expression and Role of Ceramide Synthase-2 in the Lung: Insight from Human Lung Cells and Mouse Models
Irina Petrache et al.
PLOS ONE (2013)
Crystal Structure of the Pleckstrin Homology Domain from the Ceramide Transfer Protein: Implications for Conformational Change upon Ligand Binding
Jennifer Prashek et al.
PLOS ONE (2013)
p53 N-terminal phosphorylation: a defining layer of complex regulation
Lisa M. Miller Jenkins et al.
CARCINOGENESIS (2012)
Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy
R. David Sentelle et al.
NATURE CHEMICAL BIOLOGY (2012)
Conserved Catalytic Residues of the ALDH1L1 Aldehyde Dehydrogenase Domain Control Binding and Discharging of the Coenzyme
Yaroslav Tsybovsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Interaction of the p53 DNA-Binding Domain with Its N-Terminal Extension Modulates the Stability of the p53 Tetramer
Eviatar Natan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide
Susanne Schiffmann et al.
BIOCHEMICAL PHARMACOLOGY (2010)
c-Myc Is a Nrf2-Interacting Protein that Negatively Regulates Phase II Genes Through Their Electrophile Responsive Elements
Smadar Levy et al.
IUBMB LIFE (2010)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
p53 Research: The Past Thirty Years and the Next Thirty Years
David Lane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding
Xingming Deng et al.
BLOOD (2009)
A Ceramide-binding C1 Domain Mediates Kinase Suppressor of Ras Membrane Translocation
Xianglei Yin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2009)
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
Archana Mukhopadhyay et al.
FASEB JOURNAL (2009)
The Proapoptotic C16-ceramide-Dependent Pathway Requires the Death-Promoting Factor Btf in Colon Adenocarcinoma Cells
Anne-Francoise Renert et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Transcriptional control of human p53-regulated genes
Todd Riley et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C-elegans
Xinzhu Deng et al.
SCIENCE (2008)
Ceramide recruits and activates protein kinase C ζ (PKCζ) within structured membrane microdomains
Todd E. Fox et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tailoring structure-function and targeting properties of ceramides by site-specific cationization
Zdzislaw M. Szulc et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Dual-site regulation of MDM2 E3-ubiquitin ligase activity
Maura Wallace et al.
MOLECULAR CELL (2006)
Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
Jacek Bielawski et al.
METHODS (2006)
Solution structure of p53 core domain:: Structural basis for its instability
JMP Cañadillas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The central region of HDM2 provides a second binding site for p53
GW Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The complexity of p53 stabilization and activation
M. F. Lavin et al.
CELL DEATH AND DIFFERENTIATION (2006)
Direct binding to ceramide activates protein kinase Cζ before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells
GH Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
The complex life of simple sphingolipids
AH Futerman et al.
EMBO REPORTS (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
NAD+ modulates p53 DNA binding specificity and function
KG McLure et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Critical role for a central part of Mdm2 in the ubiquitylation of p53
E Meulmeester et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Critical contribution of the MDM2 acidic domain to p53 ubiquitination
H Kawai et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
